drugset / Trial / NCT02205931

Summary

Epilepsy, a condition where individuals are prone to recurrent epileptic seizures, is the most common chronic neurological disorder in children. Epilepsy onset is most common in the first two years of life and is associated with poor prognosis for seizure control and neurodevelopmental outcome. The ketogenic diet (KD) is a medically supervised diet that is high in fat and restricted in carbohydrates and protein. KD therapy has shown to be an effective treatment for seizures in children with epilepsy older than two. Associated benefits include: a reduced requirement for routine and emergency antiepileptic drugs (AED) and fewer seizure related hospital admissions. Although reports suggest that KD therapy improves seizures in younger children there is no high quality trial data that demonstrates effectiveness and safety in this age group. The KD is resource intensive, requiring dietetic and physician time; data is required to justify expansion of services to cater for the apparent need. The investigators therefore propose a prospective multicentre randomised trial to investigate the effectiveness and safety of the KD in children with epilepsy under the age of 2, who have failed to respond to two or more AEDs. Children will be randomly assigned to either receive the KD or further AEDs. The allocated treatment will be started after a 2week baseline period, and it's effectiveness assessed after 8 weeks. Seizure diaries will be used to record seizures and related events, a questionnaire will be used to assess diet tolerance; also growth and blood biochemistry will be monitored. The information obtained from this study is necessary to optimise choices in epilepsy treatment, aiming to improve outcomes and thus determine whether and when the KD should should be used.

Timeline

Start
2015-01
Primary completion
2018-06
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule
Comparator Clobazam Small molecule
Comparator Clonazepam Small molecule
Comparator Ethosuximide Small molecule
Comparator Lamotrigine Small molecule
Comparator Levetiracetam Other / unclassified
Comparator Phenytoin Unknown
Comparator Rufinamide Small molecule
Comparator Stiripentol Small molecule
Comparator Topiramate Small molecule
Comparator Valproate Small molecule
Comparator Vigabatrin Small molecule
Comparator Zonisamide Other / unclassified
Comparator nitrazepam Small molecule

Indications